## Abstract ## BACKGROUND Malignant tumors of the skull base are rare. Therefore, no single center treats enough patients to accumulate significant numbers for meaningful analysis of outcomes after craniofacial surgery (CFS). The current report was based on a large cohort that was analyzed retrosp
โฆ LIBER โฆ
High activity I-125 endocurietherapy for skull base tumors
โ Scribed by P. Pradeep Kumar
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 119 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Craniofacial surgery for malignant skull
โ
Snehal G. Patel; Bhuvanesh Singh; Ashok Polluri; Patrick G. Bridger; Giulio Cant
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 93 KB
๐ 2 views
Interstitial implantation of high-activi
โ
Steven A. Leibel; Philip H. Gutin; Theodore L. Phillips; William M. Wara; Keith
๐
Article
๐
1984
๐
Elsevier Science
๐
English
โ 233 KB
Feasibility of intraoperative motor-evok
โ
Kimiaki Hashiguchi; Takato Morioka; Fumiaki Yoshida; Koji Yoshimoto; Tadahisa Sh
๐
Article
๐
2011
๐
Springer Vienna
๐
English
โ 348 KB
Microsurgical resection and I-125 brachy
โ
Philip H. Gutin; Steven A. Leibel; Yoshio Hosobuchi; Theodore L. Phillips
๐
Article
๐
1982
๐
Elsevier Science
๐
English
โ 250 KB
Complications of craniofacial resection
โ
Ian Ganly; Snehal G. Patel; Bhuvanesh Singh; Dennis H. Kraus; Patrick G. Bridger
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 81 KB
๐ 1 views
Radiosynthesis of high effective specifi
โ
Stephen M. Moerlein; David Parkinson; Michael J. Welch
๐
Article
๐
1990
๐
Elsevier Science
โ 478 KB
The high yield, high-specific activity radiosynthesis of the dopaminergic D-1 receptor-binding ligand [123I]SCH 23982 is described. Using no-carrier-added iododeprotonation of the des-iodo precursor SKF 83692 and column-switching HPLC, [123I]SCH 23982 was isolated in 35-40% radiochemical yield with